231 related articles for article (PubMed ID: 35760230)
1. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
[TBL] [Abstract][Full Text] [Related]
2. Cadmium exposure exacerbates immunological abnormalities in a BTBR T
Albekairi TH; Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almanaa TN; Alwetaid MY; Alqinyah M; Alnefaie HO; Ahmad SF
J Neuroimmunol; 2024 Jan; 386():578253. PubMed ID: 38064869
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
[TBL] [Abstract][Full Text] [Related]
4. Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T
Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Albekairi TH; Bakheet SA; Alobaidi AF; Alhosaini K; Alqarni SA; Ibrahim KE; Alsaad AMS; Ahmad SF
Immunol Lett; 2022 Apr; 244():19-27. PubMed ID: 35259423
[TBL] [Abstract][Full Text] [Related]
5. Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T
Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almutairi MM; Albekairi TH; Hussein MH; Al-Hamamah MA; Ahmad SF
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047547
[TBL] [Abstract][Full Text] [Related]
6. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
[TBL] [Abstract][Full Text] [Related]
7. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM
Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114
[TBL] [Abstract][Full Text] [Related]
8. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM
Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190
[TBL] [Abstract][Full Text] [Related]
9. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Alzahrani MZ; Bakheet SA; Attia SM
Neuromolecular Med; 2018 Mar; 20(1):133-146. PubMed ID: 29468499
[TBL] [Abstract][Full Text] [Related]
12. The Exposure to Lead (Pb) Exacerbates Immunological Abnormalities in BTBR T
Assiri MA; Albekairi TH; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Shahid M; Aldossari AA; Almutairi MM; Almanaa TN; Alwetaid MY; Ahmad SF
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003408
[TBL] [Abstract][Full Text] [Related]
13. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF
J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207
[TBL] [Abstract][Full Text] [Related]
14. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
[TBL] [Abstract][Full Text] [Related]
15. CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T
Albekairi NA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Alanazi MM; Alhamed AS; Albekairi TH; Al-Mazroua HA; Ibrahim KE; Ahmad SF
Pharmacol Biochem Behav; 2022 Jun; 217():173408. PubMed ID: 35644272
[TBL] [Abstract][Full Text] [Related]
16. Aflatoxin B
Alwetaid MY; Almanaa TN; Bakheet SA; Ansari MA; Nadeem A; Attia SM; Hussein MH; Ahmad SF
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002479
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M
Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585
[TBL] [Abstract][Full Text] [Related]
18. The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alshammari MA; Attia SM
Neurochem Int; 2018 Nov; 120():251-261. PubMed ID: 30227151
[TBL] [Abstract][Full Text] [Related]
19. Methylmercury chloride exposure aggravates proinflammatory mediators and Notch-1 signaling in CD14
Ahmad SF; Bakheet SA; Ansari MA; Nadeem A; Alobaidi AF; Attia SM; Alhamed AS; Aldossari AA; Mahmoud MA
Neurotoxicology; 2021 Jan; 82():9-17. PubMed ID: 33166615
[TBL] [Abstract][Full Text] [Related]
20. The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Mazroua HA; Khan MR; Alasmari AF; Alanazi WA; As Sobeai HM; Attia SM
Mol Immunol; 2019 Oct; 114():561-570. PubMed ID: 31522074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
